Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Lower Newborn Bone Mineral Content Associated with Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Siberry GK, Jacobson DL, Kalkwarf HJ, Wu JW, Dimeglio LA, Yogev R, Knapp KM, Wheeler JJ, Butler L, Hazra R, Miller TL, Seage GR 3rd, Van Dyke RB, Barr E, Davtyan M, Mofenson LM, Rich KC; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2015 Jun 9. pii: civ437. [Epub ahead of print]

PMID:
26060285
2.

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.

Siberry GK, Warshaw MG, Williams PL, Spector SA, Decker MD, Jean-Philippe P, Yogev R, Heckman BE, Manzella A, Roa J, Nachman S, Lujan-Zilbermann J; IMPAACT P1065 Protocol Team.

Pediatr Infect Dis J. 2012 Jan;31(1):47-52. doi: 10.1097/INF.0b013e318236c67b.

3.

Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women.

Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, Bardeguez A, Stek A, Read JS; International Maternal Pediatric Adolescent AIDS Clinical Trials Group Protocol 1025 Study Team.

Obstet Gynecol. 2010 Aug;116(2 Pt 1):335-43. doi: 10.1097/AOG.0b013e3181e8f38a.

4.

Adherence to antiretrovirals among US women during and after pregnancy.

Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, Stek A, Buschur S, Cotter A, Bettica L, Read JS; PACTG 1025 Protocol Team.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):408-17. doi: 10.1097/QAI.0b013e31817bbe80.

5.

Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women.

Thorpe LE, Frederick M, Pitt J, Cheng I, Watts DH, Buschur S, Green K, Zorrilla C, Landesman SH, Hershow RC.

J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1423-30.

PMID:
15483472
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk